Keywords: genzyme, 4th, qtr, net, income, rises, corp
Genzyme 4th qtr net income rises 38%
Article | 09 March 2001
Genzyme Corp says that its fourth-quarter 2000 net income, beforespecial items and prior to purchase accounting, increased 38% to $56.3 million, or $0.60 per ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
